Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR

Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR

Item
http://www.wikidata.org/entity/Q28205980
Q28176955
sameAs
Mammalian nicotinic acetylcholine receptors: from structure to functionCurrent pharmacologic options for patients with Alzheimer's diseaseNicotinic ACh receptors as therapeutic targets in CNS disordersCellular, molecular, and genetic substrates underlying the impact of nicotine on learning.Structural answers and persistent questions about how nicotinic receptors work.Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting.Galantamine facilitates acquisition of hippocampus-dependent trace eyeblink conditioning in aged rabbitsAssessing the synergy between cholinomimetics and memantine as augmentation therapy in cognitive impairment in schizophrenia. A virtual human patient trial using quantitative systems pharmacologyNicotinic receptors in neurodegeneration.High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia.Plasma acetylcholinesterase activity correlates with intracerebral β-amyloid loadMemantine combined with an acetyl cholinesterase inhibitor - hope for the future?Nicotine aversion: Neurobiological mechanisms and relevance to tobacco dependence vulnerability.Cholinesterase inhibitors for the treatment of Alzheimer's disease:: getting on and staying on.Effects of cholinesterase inhibitors on rat nicotinic receptor levels in vivo and in vitroCholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice.Post-Injury Administration of Galantamine Reduces Traumatic Brain Injury Pathology and Improves Outcome.
P2860

Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR

Item
http://www.wikidata.org/entity/Q28205980
description
2000 nî lūn-bûn
@nan
2000 թուականին հրատարակուած գիտական յօդուած
@hyw
2000 թվականին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR
@ast
Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR
@en
Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR
@nl
type
label
Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR
@ast
Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR
@en
Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR
@nl
prefLabel
Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR
@ast
Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR
@en
Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR
@nl
P1433
P1476
P2093
P304
P31
P407
P478
P577
P698
P1433
P1476
Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR
@en
P2093
P304
P31
P407
P478
P577
P698